Celgene Corporation (NASDAQ:CELG) has been recommended as a long term growth pick according to Beta Research. With their stock price currently trading around $139.69, the firm has proven a solid track record of growth over the past few years. Investors might consider the stock as a long term growth candidate as the firm has yielded 11.80% earnings per share growth over the past 5 years and 18.30% revenue growth over that same time frame.
Let’s take a look at how the stock has been performing recently. Over the past twelve months, Celgene Corporation (NASDAQ:CELG)’s stock was 20.68%. Over the last week of the month, it was -4.37%, 4.59% over the last quarter, and 11.70% for the past six months.
Over the past 50 days, Celgene Corporation’s stock is -5.08% off of the high and 10.11% removed from the low. Their 52-Week High and Low are as follows: -5.08% (High), 44.11%, (Low).
Despite the past success, investors want to know where the stock is headed from here. Analysts covering the shares have a consensus short-term price target of $154.22 on the equity. Analysts have a consensus recommendation of 1.70 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.